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Postmortem studies, including the complete diagnostic autopsy (CDA) and the minimally invasive 
autopsy (MIA), an innovative approach to post-mortem sampling and cause of death investigation, are 
commonly performed within 24 hours after death because the quality of the tissues deteriorates over 
time. This short timeframe may hamper the feasibility of the procedure. In this study, we compared 
the diagnostic performance of the two postmortem procedures when carried out earlier and later than 
24 hours after death, as well as the impact of increasing postmortem intervals (PMIs) on the results 
of the microbiological tests in a series of 282 coupled MIA/CDA procedures performed at the Maputo 
Central Hospital in Mozambique between 2013 and 2015. 214 procedures were conducted within 
24 hours of death (early autopsies), and 68 after 24 hours of death (late autopsies). No significant 
differences were observed in the number of non-conclusive diagnoses (2/214 [1%] vs. 1/68 [1%] 
p = 0.5645 for the CDA; 27/214 [13%] vs. 5/68 [7%] p = 0.2332 for the MIA). However, increasing PMIs 
were associated with a raise in the number of bacteria identified (rate: 1.014 per hour [95%CI: 1.002–
1.026]; p = 0.0228). This increase was mainly due to rising numbers of bacteria of the Enterobacteriaceae 
family and Pseudomonas genus strains. Thus, performing MIA or CDA more than 24 hours after death 
can still render reliable diagnostic results, not only for non-infectious conditions but also for many 
infectious diseases, although, the contribution of Enterobacteriaceae and Pseudomonas spp. as 
etiological agents of infections leading to death may be overestimated.
The minimally invasive autopsy (MIA) is a postmortem diagnostic method based on obtaining samples of body 
fluids and key organs using needle biopsies. Such an approach has been designed as a potential alternative of the 
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complete diagnostic autopsy (CDA)1 in resource limited settings. The MIA requires lower levels of expertise and 
infrastructures than the CDA1 and there are data showing a high level of interest in knowing cause of death and 
potential acceptability in low- and middle-income countries2. Moreover, the use of needles without manipulation 
of the organs allows collecting samples for microbiology analysis with lower risk of contamination compared with 
CDA. The procedure has recently been validated in Mozambique in all age groups, including stillbirths, neonates, 
children, adults and maternal deaths3–6. In this validation analysis, the concordance with the CDA, the gold stand-
ard for cause of death determination, was moderate to good, and the MIA reliably recognized most infectious dis-
eases and cancers causing death. This new method has raised high expectations among global health researchers 
because it may provide more robust explanations for the cause of death than other currently used approaches7–9.
To deploy such methods to study mortality in low- and middle-income countries, we need to understand the 
timeframe limits whereby the results of a MIA are adequate, which have not been previously defined. However, 
data evaluating the possible effects of the postmortem interval (PMI) in the diagnostic yield of the MIA are scarce. 
In the clinical routine, the CDA is generally conducted within 24 hours after death10,11, because the quality of the 
tissues, and consequently, the quality of the results obtained, deteriorates over time due to autolysis, and other 
decay processes that affect the body12. One of these phenomena is the active participation of microorganisms in 
the decomposition of bodies. Temperature and anaerobic conditions have been proposed as major factors driving 
the decomposition process13,14. The bacterial translocation, a phenomenon that rapidly initiates following death 
and by which viable bacteria originating principally from the intestinal microbiota migrate to other organs, may 
pose challenges when trying to ascertain the contribution of detected microorganisms to the fatal event. Indeed, 
judging whether a potentially pathogenic microorganism is the expression of a true ante-mortem bacterial infec-
tion or a false-positive result related to events occurring after death is not straightforward15,16. Understandingly, 
general consensus recommends conducting any postmortem evaluation as soon as possible following death, once 
the family consent has been obtained. However, such short timeframes may hamper the feasibility of the MIA 
procedure, particularly when implemented in health facilities from rural areas where many deaths occur at home 
and it may take some time to reach the health facility.
When designing the MIA protocol, a period of 24 hours after death was established as the maximum “ideal 
time” to perform the procedure. However, due to a variety of circumstances, some of the autopsies were per-
formed after this timeframe. In this study, we aimed to evaluate the impact of the PMI on the diagnostic per-
formance of the MIA and the CDA and provide information on the timeframe limits in which the results of a 
postmortem evaluation may be adequate.
Methods
Study setting and design. This analysis derives from the CaDMIA project, a validation study of the MIA 
vs. the CDA in different age groups. The study was conducted at the Department of Pathology of the Maputo 
Central Hospital, a 1500-bed government-funded tertiary health care center, in collaboration with the depart-
ments of medicine, obstetrics and gynecology, and pediatrics. The study received the approval of the National 
Bioethics Committee of Mozambique (Ref. 342/CNBS/13) and the Clinical Research Ethics Committee of the 
Hospital Clinic of Barcelona in Spain (Ref: 2013/8677). All research was performed in accordance with rele-
vant guidelines and regulations of the Montreal Statement on Research Integrity in Cross-Boundary Research 
Collaborations, and the Singapore Statement on Research Integrity.
Deaths of all ages having occurred within the hospital premises from November 2013 to March 2015 were sub-
mitted to coupled MIA and CDA procedures. Eligible criteria for case recruitment were: 1) an autopsy requested 
by the clinician as part of the medical evaluation of the patient, and 2) informed consent to perform the autopsy 
given by the relatives. Accidental or traumatic deaths were excluded.
Autopsy procedures. Detailed MIA pathological and microbiological methods have been reported else-
where1,3–6. In brief, the procedure included an initial disinfection of the surface of the body followed by the col-
lection of blood and cerebrospinal fluid (CSF), aiming to collect ~10–15 mL of each fluid, and puncture of solid 
organs (liver, lungs, and central nervous system [CNS]) using biopsy needles (14G-16G), for microbiological 
and pathological analysis. In addition, punctures aiming to obtain heart, spleen, kidneys and, in maternal deaths, 
uterus, were performed for pathology examination.
Immediately after the MIA, the CDA procedure was conducted by a second pathologist not involved with the 
MIA and following a standardized protocol for adult deaths17 or pediatric and perinatal deaths18. Histological and 
microbiological samples were obtained from the same viscera collected in the MIA and CDA, as well as from any 
grossly identified lesions. Time of death and start of MIA and CDA procedures were recorded for all cases.
Histological and microbiological analyses. The histological evaluation included staining with hema-
toxylin and eosin in all samples and additional histochemical and/or immunohistochemical staining whenever 
needed to reach a diagnosis1,3–6. All microbiological methods, that included both culture and molecular tests, 
have been reported in detail elsewhere15,19. Microbiological cultures were performed only with the fluids and 
tissues obtained in the MIA. Briefly, 5–10 mL of blood were inoculated into aerobic blood culture bottles and 
incubated into the BACTEC system (Beckton Dickinson, MD, USA). Positive blood cultures were subjected to 
Gram stain and sub-cultured in agar plates according to the morphology observed under the microscope. CSF 
samples were sub-cultured into blood, chocolate and MacConkey agar plates, because between all these culture 
media allow the recovery of the maximum amount of cultivable microorganisms with medical interest. Tissue 
samples from CNS, liver, lung and uterus were inoculated into thioglycolate broth-containing tubes, a multipur-
pose, enriched, differential medium and incubated at 37 °C. If signs of bacterial or fungal growth were observed, 
Gram stain and sub-culture into appropriate agar plates for the recovery of bacteria were performed; if yeasts were 
observed in the gram stain or if fungal filamentous growth were observed, sub-cultured into appropriate media 
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was performed. Identification of the isolates was performed by standard biochemical techniques at the laboratory 
of the Manhiça Health Research Center (CISM). The strains were kept at −80 °C until shipment to the Hospital 
Clinic of Barcelona for final identification by matrix assisted laser desorption/ionization (MALDI-TOF, Bruker 
Daltonik GmbH, Bremen, Germany).
Molecular analyses were performed both in body fluids and tissues obtained in the MIA and in tissues 
obtained in the CDA. For these analyses, plasma and CSF aliquots, as well as tissue samples, were stored at −80 °C 
until testing. All tissue samples obtained through MIA and CDA procedures were homogenized using a hand-
held rotor-stator homogenizer (TissueRuptor, Qiagen) and disposable probes for each tissue sample processed. 
Nucleic acid extractions (DNA + RNA) were performed using a semi-automated system (Qiacube, Qiagen). For 
formalin-fixed paraffin embedded (FFPE) tissues, three thick sections of 10 μm were prepared. The microtome 
blade was replaced after each case to avoid cross-contamination. Nucleic acid extraction included overnight 
proteinase K digestion and DNA isolation using a commercially available kit (QIAamp DNA minikit, Qiagen) 
according to the manufacturer’s instructions. DNA from whole blood collected in filter paper was subjected to 
DNA extraction using PurelinkTM Genomic DNA Kit (Invitrogen, Waltham MA, USA).
We performed generic PCRs (16S rRNA PCR and 18S rRNA-ITS PCR) and specific PCR (e.g. cytomegalovirus 
real-time PCR, Toxoplasma gondii real time PCR, Pneumocystis jirovecii real time PCR, Mycobacterium tubercu-
losis real time PCR, multiplex respiratory virus RT-PCR, P. falciparum real time PCR)18. All sequencing reactions 
from amplicons obtained by either the 16S rRNA PCR or the 18S rRNA-ITS PCR were performed by the Sanger 
method. Pathogen identification was performed by comparison of the sequences obtained with those present in 
the GenBank using the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Two scales ranging from 0 to 4 were developed to grade the strength of the evidence of the findings; one based 
on the severity of the pathological findings and the other on the pathogenicity of each individual microorganism, 
the number of organs (one or more organs) and the type of techniques (classic cultures, molecular tests or both) 
in which the microorganism was identified3–6. Microorganisms were categorized as causing true infection or as 
contaminants based on criteria previously reported by our group, which varied slightly for adults, children, neo-
nates and stillborn babies3–6. Briefly, these criteria comprised the type of microorganism, the number of organs 
involved, the presence or absence of pathologic findings associated with the infection, and the clinical data (for 
the CDA). The true infection category included infections causing death and infections present during life as 
associated conditions. Any other microorganism identified not fulfilling these criteria were classified as contam-
inant microorganisms.
Cause of death determination. Once all the analyses of the MIA samples had been completed, a panel 
composed of a pathologist, a microbiologist, and a clinician with expertise in infectious diseases and epidemi-
ology evaluated all the pathological and microbiological results and assigned the MIA diagnosis, following a 
methodology previously descibed3–6.
Whenever identified, a chain of conditions leading to death (up to four) was recorded following the most 
probable chronological sequence of events1,3–6. The direct cause of death was considered as the main cause of 
death (e.g. bacterial pneumonia in a toddler with malnutrition, or lymphoma in an HIV-infected patient), only in 
the group of maternal death we considered the underlying disease as cause of death. Finally, other conditions or 
concomitant infections contributing to death but not related to the chain of events leading to death were consid-
ered as other significant conditions.
After a washout period (minimum 3 months, range 3–6 months), and blindly to the MIA diagnosis, the same 
team analyzed the samples of the CDA following the same approach used for the analysis of the MIA samples, 
with the only exception that tissues obtained during CDA were not routinely cultured, and only molecular meth-
ods were used to investigate pathogens. The panel evaluating the CDA integrated all the findings including not 
only the pathological and microbiological results, but also the clinical information and the macroscopic data.
Using a combination of the strength of the evidence of the histological and the microbiological findings, a cat-
egory was assigned to the certainty of the cause of death attribution of the MIA diagnosis and the CDA diagnosis. 
These categories included no diagnosis and diagnosis of low, moderate, high, and very high certainty3–6.
The CDA diagnosis was considered the “gold standard”. Diagnoses were grouped into infectious diseases, 
non-infectious diseases and non-conclusive.
Time lapse between death and postmortem procedures and definition of the study groups. The 
day and time of death (with a precision of minutes) as well as the exact day and time when the MIA procedure 
started were recorded for each case. The PMI was defined as the time from death to the MIA procedure. For stillborn 
babies in whom the precise time of death was not clearly defined, the PMI was defined as the time from delivery to 
the MIA. All cases were classified in two groups: a) cases in which the autopsy procedures started within the first 
24 hours after death (“early autopsy” group); and b) all cases in which the autopsy procedures started after the first 
24 hours after death (“late autopsy” group). The microorganisms identified, as well as the technique in which they 
were identified were correlated with the PMI. The bodies were kept under refrigeration from death until the post-
mortem procedure.
Statistical methods and definitions. We compared the differences in the distribution of causes of death 
and the percentage of inconclusive cases observed in early and late autopsies. The differences were assessed using 
the Chi-square test or Fisher’s exact test. The differences in levels of strength and certainty between early and late 
MIAs were analyzed using the Student’s t-test for independent groups and Fisher’s exact test respectively. The 
coincidence between the MIA and the CDA diagnoses was evaluated, by comparing the ICD-10 codes of the main 
diagnosis3–6. As the ICD-10 system classifies diagnoses into nested classes of different hierarchical levels in which 
diseases or conditions are organized in chapters, blocks, and 3-character categories, a coincidence was classified 
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as (i) perfect; (ii) moderate; or (iii) low20. When the MIA and the CDA diagnoses were in different chapters, the 
coincidence was classified as “none”.
For the microbiological tests, we analyzed both for the MIA (cultures and molecular tests) and the CDA (only 
molecular tests) the association between the microorganisms identified and the elapsed time after death. The 
sample performance was assessed using the following indicators: number of tests and number of tests with a pos-
itive result (detection of one or multiple microorganisms in a culture or in a molecular test). The positive results 
were divided into positive results due to microorganisms considered as contaminants (microorganism considered 
as associated with translocation and not causing disease) and positive results due to microorganisms considered 
as responsible of true infections (detection of microorganisms considered as associated with disease).
The analysis was stratified by the type of microbiological test used to identify the pathogen (culture or molec-
ular test). The number of tests with positive results was analyzed as count data potentially with excess zeros, 
since the number of tests performed was not the same for all cases. Hence, zero inflated Poisson regression mod-
els (ZIP) or standard Poisson regression as appropriate according to the Vuong test21 were estimated using the 
number of tests as inflation factor and standard errors clustered at case level, relaxing the usual requirement that 
the observations be independent. The ZIP models were essentially two-stage models in which the probability of 
being tested was estimated first, followed by the estimation of Poisson regression among cases with a nonzero 
probability of being tested.
The concordance between MIA and CDA was assessed by the Cohen’s Kappa statistic and differences were 
assessed based on Student’s t distribution of 1000 bootstrap replications of paired differences for comparing cor-
related kappa coefficients22.
Statistical analyses were performed using Stata version 14.1 (Stata, College Station, TX, USA)23.
Ethics approval and consent to participate. The study protocol received approval of the National 
Mozambican Ethics Committee (ref.342/CNBS/13) and the Ethics Committee of the Hospital Clinic of Barcelona 
(Spain; approved, File 2013/8677). MIA and CDA procedures were only conducted after verbal informed consent 
was provided by the relatives.
Results
Coupled MIA and CDA procedures were performed in 282 individuals including 18 stillborn babies, 41 neonates, 
54 children, 57 maternal deaths and 112 other adults older than 15 years.
Two hundred fourteen (75.9%) MIA/CDA procedures were conducted within the first 24 hours (early autop-
sies) and 68 (24.1%) more than 24 hours after death (late autopsies). In the early autopsy group, the median 
time after death was 14 hours (range 4–24 hours). In this group 12 (5.6%) cases were stillborn babies, 29 (13.6%) 
were neonates, 33 (15.4%) were children, 37 (17.3%) were women of childbearing age, and finally 103 (48.1%) 
were other adults. In the group of late autopsies, the median time after death was 27 hours (range 24–65 hours). 
Of them, 6 (8.9%) were stillborn babies, 12 (17.6%) were neonates, 21 (30.9%) were children, 20 (29.4%) were 
maternal deaths, and 9 (13.2%) were other adults. In this group the procedures were performed between 24 and 
36 hours after death in 52 cases (76.5%), and after 36 hours or more after death (range 36–64 hours) in 16 cases 
(23.5%).
Table 1 shows the causes of death grouped by main categories (i.e. infectious vs. non-infectious, vs. no diagno-
sis) identified at the CDA (gold standard) in the different groups of patients. No differences were observed either 
in terms of diagnostic distribution between the early autopsies and the late autopsies or in the number of cases 
with non-conclusive diagnosis.
Level of strength of the findings, level of certainty of the diagnoses and coincidence between 
the mia and the cda. No significant differences were found in the mean level of strength of the pathologi-
cal and microbiological findings of the MIA and the CDA between early and late autopsy groups, with the only 
exception of a slightly lower level of strength of the pathological findings in the CDA in the late autopsy group (3.6 
in the early, vs. 3.3 in the late, p = 0.0155) (see Supplementary Information Table 1).
Table 2 shows the level of certainty of the MIA and the CDA diagnoses in the early and late autopsy groups. No 
significant differences were identified between the two groups.
Table 3 shows the concordance between the MIA and the CDA diagnoses in early and late autopsy groups. No 
differences were observed in any of the age groups.
Relationship between the pmi and identification of microorganisms. Figure 1 shows the relation-
ship between the estimated rates of microorganisms identified and the PMI. The list of microorganisms identified 
in this study is shown in Supplementary Table 2. The results of the microorganisms classified as contaminants 
are presented in Fig. 1A,B, and those of the microorganisms considered as associated with true infections (either 
as direct causes of death, involved in the chain of events leading to death or present during life as associated 
conditions) in Fig. 1C,D. The estimations for the conventional cultures are shown in graphics 1A and 1C and 
those of the molecular tests in graphics 1B and 1D. For the molecular tests, the graphics include the estimations 
for the MIA (in green) and the CDA (in blue). Long PMI were associated with higher rates of contaminants in 
the conventional cultures and in the molecular tests (Fig. 1A,B respectively). For the microorganisms considered 
as associated with true infections the PMI was only associated with a higher rate of detection in conventional 
cultures but not in the molecular tests (Fig. 1C,D respectively). This association was observed in the samples of 
the cerebrospinal fluid (p = 0.0240), the brain (p < 0.0001), the lungs (p = 0.0001), and the uterus (p = 0.0447).
Figure 2 shows the relationship between the PMI and the estimated detection rates of bacteria, fungi, viruses 
and parasites identified in the molecular tests. Long PMI was associated with high detection of bacteria in the 
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MIA samples. No relationship between the PMI and estimated detection rates of viruses (Fig. 2C). There was 
a statistically significant decrease in the identification of fungi and parasites in cases with the PMI longer than 
12 hours (Fig. 2B,D).
The analysis of the different families of bacteria showed that long PMI were associated with high rates of the 
identification of Enterobacteriaceae in the MIA samples both in conventional cultures (Fig. 3A) and in molecular 
tests (Fig. 3B). This association was not observed in the CDA samples. Increases in the PMI were associated with 
increases in the identification of Pseudomonas genus both in the MIA and in the CDA samples in the molecular 
analyses, but not in the conventional cultures (Fig. 3C,D).
Time from death to autopsy procedures
p-value*Early autopsies (n = 214) Late autopsies (n = 68) Total (n = 282)
Stillbirths 0.1787
   Infectious diseases 1 (8%) 3 (50%) 4 (22%)
   Non-infectious diseases 9 (75%) 3 (50%) 12 (67%)
   Non-conclusive 2 (17%) 0 (0%) 2 (11%)
   Total 12 (100%) 6 (100%) 18 (100%)
Neonates 0.1650
   Infectious diseases 17 (59%) 10 (83%) 27 (66%)
   Non-infectious diseases 12 (41%) 2 (17%) 14 (34%)
   Non-conclusive 0 (0%) 0 (0%) 0 (0%)
   Total 29 (100%) 12 (100%) 41 (100%)
Children 0.3291
   Infectious diseases 24 (73%) 18 (86%) 42 (78%)
   Non-infectious diseases 9 (27%) 3 (14%) 12 (22%)
   Non-conclusive 0 (0%) 0 (0%) 0 (0%)
   Total 33 (100%) 21 (100%) 54 (100%)
Maternal deaths 0.4466
   Infectious diseases 18 (49%) 8 (40%) 26 (45%)
   Non-infectious diseases 19 (51%) 11 (55%) 30 (53%)
   Non-conclusive 0 (0%) 1 (5%) 1 (2%)
   Total 37 (100%) 20 (100%) 57 (100%)
Other adults 0.7132
   Infectious diseases 74 (72%) 6 (67%) 80 (71%)
   Other Non-infectious diseases 29 (28%) 3 (33%) 32 (29%)
   Non-conclusive 0 (0%) 0 (0%) 0 (0%)
   Total 103 (100%) 9 (100%) 112 (100%)
Table 1. Causes of death identified at the complete diagnostic autopsy (gold standard) in the different groups of 
patients in the early autopsy group (performed within 24 hours of death) and the late autopsy group (performed 
more than 24 hours after death). The data are presented as absolute numbers and (percentages of the column). 
*Fisher’s exact test.
Level of certainty of the 
cause of death
Time from death to the postmortem procedures
p-valueEarly autopsies (n = 214) n (%) Late autopsies (n = 68) n (%)
Minimally invasive autopsy 0.1871*
   Very high 74 (35%) 19 (28%)
   High 52 (24%) 17 (25%)
   Moderate 36 (17%) 20 (29%)
   Low 25 (12%) 7 (10%)
   No diagnosis 27 (13%) 5 (7%)
Complete diagnostic autopsy 0.8169#
   Very high 93 (43%) 26 (38%)
   High 80 (37%) 28 (41%)
   Moderate 29 (14%) 11 (16%)
   Low 10 (5%) 2 (3%)
   No diagnosis 2 (1%) 1 (1%)
Table 2. Level of certainty of the MIA and the CDA diagnoses in the early (performed within 24 hours of death) 
and the late autopsy groups (performed more than 24 hours after death). *Chi-square test; #Fisher’s exact test.
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There were borderline significant differences in the number of patients considered to have died of infections 
caused by strains of Enterobacteriaceae family or Pseudomonas genus between the early and the late autopsy 
groups (15/214 [7.0%] vs. 10/68 [14.7%] (p = 0.0518). When adding to these patients, the cases in which these 
bacteria were considered as having contributed to the death (addition of infections included in the chain of events 
leading to death, but not directly having caused the death and the infections considered as other significant con-
ditions) the differences became significant with less deaths attributed to these bacteria in the early autopsy group 
(19/214 [8.9%]) than in the late autopsy group (13/68 [19.1%]) (p = 0.0204).
Finally, in only one of the 15 patients (6.7%) of the early autopsy group and in 2/10 (20.0%) of the late autopsy 
group, who were considered to have died of infections caused by strains of the Enterobacteriaceae family or 
Pseudomonas genus, the final diagnosis was established based on very low pathological evidence and, conse-
quently it was mainly based on the microbiological evidence.
Group
Time from death to the postmortem procedures
p-value†






Stillbirths 10/12 (83%) 0.7576 5/6 (83%) 0.7692 0.9698
Neonates 18/29 (62%) 0.3794 10/12 (83%) 0.4419 0.8618
Children 28/33 (85%) 0.6429 20/21 (95%) 0.8372 0.4583
Maternal deaths 24/37 (65%) 0.4025 15/20 (75%) 0.6183 0.2376
Other adults 89/103 (86%) 0.7274 8/9 (89%) 0.7857 0.7679
Table 3. Concordance between the MIA and the CDA in the early (performed within 24 hours after death) 
and the late autopsy groups (performed more than 24 hours after death). Number of cases classified in the 
same disease group by MIA and CDA; #Concordance between the MIA and the CDA; †Based on Student’s t 
distribution of 1000 bootstrap replications of paired differences
Figure 1. Relationship between the estimated rates of microorganisms identified and the postmortem interval. 
Microorganisms classified as contaminants are shown in (A,B) and the microorganisms considered as associated 
with true infections in (C,D). The estimations for the conventional cultures are shown in graphics (A,C) and 
those of the molecular tests in graphics (B,D). For the molecular tests, the graphics include the estimations for the 
minimally invasive autopsy (MIA, in green) and the complete diagnostic autopsy (CDA, in blue).
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Discussion
The appearance of the minimally invasive autopsy for post-mortem sampling to investigate the causes of death 
has stirred a significant revolution in the way we study mortality in low-income settings. However, short time-
frames after death may hamper the feasibility of the MIA procedure when implementing the tool in low and 
middle-income countries, particularly in health facilities located in rural areas. For this reason, it appears relevant 
to generate evidence about the robustness of the data provided through the MIA beyond the first 24 hours after 
death.
In our study, no variations were observed related to the PMI in the number of cases in which no final diagnosis 
of cause of death was reached between the MIA and the CDA. Moreover, no diagnostic differences were observed 
between procedures performed earlier and later than 24 hours after death3–6. No differences were observed either 
regarding the level of between the MIA and the CDA diagnosis between the early and the late autopsy groups 
and no variations were observed either for the non-infectious conditions or for most of the infectious diseases. 
In particular, the microbiological results related to fungi and viruses seem not to be affected by changes related to 
the PMI and are, consequently, reliable23,24. These findings indicate that the MIA and the CDA, performed more 
than 24 hours after death can yield reliable results, and support their use after this period.
However, our study showed raising numbers of bacteria identified in the MIA (rate: 1.014 per hour [95%CI: 
1.002–1.026]; p = 0.0228) with increasing PMI. This raise in the number of identified microorganisms with 
increasing PMI was evident for contaminating bacteria, but an increase was also observed in the number of bac-
teria considered as associated with true infections according to our criteria. This increase was mainly related with 
increases in the number of Enterobacteriaceae family and Pseudomonas genus strains.
In our study, the classification of a microorganism as a contaminant or as a microorganism associated with 
true infection was largely based on a grading scheme, which depend on the internal validity of the results 
obtained from the microbiology tests3–6. This grading scheme to determine the level of strength of a particular 
finding was applied not only to the microbiological results, but also to the pathological findings. For the micro-
biological findings, these criteria were based on the pathogenicity of each individual microorganism, but also on 
the number of organs (one or more organs) and the type of techniques (classic cultures, molecular tests or both) 
in which the microorganism was identified3–6. Accordingly, whereas some microorganisms such as Cryptococcus 
spp. or M. tuberculosis were always considered as associated with true infections, other microorganisms such 
as Enterobacteriaceae could be considered as contaminants or as associated with true infections depending on 
whether they have been isolated in a single or in multiple organs and on whether they had been identified by 
cultures, molecular tests or by both techniques simultaneously. However, these criteria are obviously influenced, 
not only by the sensitivity and specificity of the tests, but also by the quality of the samples.
Figure 2. Relationship between the postmortem interval and the estimated detection rates of bacteria (A), 
fungi (B), viruses (C) and parasites (D) identified in the molecular tests. The graphics include the estimations 
for the minimally invasive autopsy (MIA, in green) and the complete diagnostic autopsy (CDA, in blue).
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The results of this study indicate that the abovementioned criteria may overestimate the contribution of 
Enterobacteriaceae and Pseudomonas spp. as responsible of infections leading or contributing to death, par-
ticularly in procedures performed more than 24 hours after death. The higher number of deaths attributed to 
these microorganisms in the late autopsy group (10/68 [14.7%] vs. 15/214 [7.0%] in the early autopsy group, 
p = 0.0518), and of infections contributing to death (13/68 [19.1%] in the late autopsy group vs. 19/214 [8.9%] in 
the early autopsy group, p = 0.0204) are in keeping with this hypothesis. However, the number of cases in which 
the diagnosis was established based only on the microbiological criteria, which might represent true over diagno-
sis, was very small (3 cases) whereas most of the cases had strong pathological evidence and represented only an 
overestimation of the etiological agent.
Bacterial translocation is a physiologic phenomenon that occurs during life and after death15. Viable bacteria 
originating principally from the intestinal microbiota have been isolated in samples (such as blood) taken from 
human bodies, providing evidence that this bacterial translocation occurs before death16. The three main factors 
resulting in this phenomenon in the living human (intestinal mucosa alteration, modification of the intestinal 
microbiota, and a weak immune system) also occur after death25. However, the results reported in the literature 
about the relationship between the PMI and detection of microorganisms are diverse. There is some controversy 
regarding the effect of the PMI on bacterial isolation rates. It has been reported a small effect of the PMI on the 
isolation rates in cultures from blood and CSF13; in contrast, other studies have shown that the PMI have no 
influence on bacterial growth26. However, in the latter series no sample was taken beyond 48 hours and only pure 
growth of potentially pathogenic bacteria were included in the analysis. Published data showing that Escherichia 
coli, Klebsiella pneumoniae, Clostridium spp, P. aeruginosa, Enterococci, and Streptococci have a higher potential 
of translocation27,28, are in keeping with our findings and stress the need of considering the PMI when evaluating 
the microbiological results related to these bacteria. Finally, a longer PMI was associated with an increase in the 
number of Pseudomonas spp. strains detected with molecular techniques. In contrast, an increased PMI was not 
associated with an increase in the number of strains of this genus in conventional cultures. This may be related 
to the low number of translocated bacteria, which can be detected by molecular tools but not by culture, because 
anaerobic strains limit the growth of species with high translocation potential28.
In our study, the bodies were refrigerated between the time of death and the autopsy procedures. However, 
some delays in the refrigeration with bodies exposed to high temperatures cannot be excluded. Refrigeration has 
been shown to reduce autolysis29,30 and bacterial translocation13,31, and consequently expand the period in which 
the postmortem pathological and microbiological analyses are reliable. Inaccessibility to refrigeration may reduce 
the efficiency interval and thus hinder the performance of the postmortem examination.
Figure 3. Relationship between the postmortem interval and the estimated detection rates of 
Enterobacteriaceae in cultures (A), and in molecular tests (B), Pseudomonadaceae in cultures (C), and in 
molecular tests (D). For molecular tests, the graphics include the estimations for the MIA (in green) and the 
CDA (in blue).
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In conclusion, the MIA and the CDA, performed more than 24 hours after death can yield reliable 
results, provided bodies have been kept under adequate refrigeration. However, the contribution to death of 
Enterobacteriaceae and Pseudomonas spp. infections may be overestimated, particularly in procedures performed 
more than 24 hours after death. Thus, these bacteria should be probably disregarded as cause or contributors to 
death when evaluating autopsy procedures performed more than 24 hours after death. Further studies are needed 
to determine the maximum time beyond which such investigations using pathological and microbiological meth-
ods are likely to no longer provide valuable results.
Availability of data and material
All relevant data are within the paper. Any additional data use and transfer is monitored by ISGlobal’s Data Man-
agement and Biostatistics Unit (contact e-mail: ubioesdm@isglobal.org).
References
 1. Castillo, P. et al. Pathological methods applied to the investigation of causes of death in developing countries: Minimally invasive 
autopsy approach. PLoS One 10, https://doi.org/10.1371/journal.pone.0132057 (2015).
 2. Maixenchs, M. et al. Willingness to Know the Cause of Death and Hypothetical Acceptability of the Minimally Invasive Autopsy in 
Six Diverse African and Asian Settings: A Mixed Methods Socio-Behavioural Study. PLoS Med. 13, https://doi.org/10.1371/journal.
pmed.1002172 (2016).
 3. Menendez, C. et al. Validity of a minimally invasive autopsy for cause of death determination in stillborn babies and neonates in 
Mozambique: An observational study. PLoS Med. 14, https://doi.org/10.1371/journal.pmed.1002318 (2017).
 4. Bassat, Q. et al. Validity of a minimally invasive autopsy tool for cause of death determination in pediatric deaths in Mozambique: 
An observational study. PLoS Med. 14, https://doi.org/10.1371/journal.pmed.1002317 (2017).
 5. Castillo, P. et al. Validity of a minimally invasive autopsy for cause of death determination in adults in mozambique: an observational 
study. PLoS Med. 13 https://doi.org/10.1371/journal.pmed.1002171 (2016).
 6. Castillo, P. et al. Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An 
observational study. PLoS Med. 14, https://doi.org/10.1371/journal.pmed.1002431 (2017).
 7. Bassat, Q. et al. Development of a post-mortem procedure to reduce the uncertainty regarding causes of death in developing 
countries. Lancet Glob. Heal. 1, 125–126 (2013).
 8. Byass, P. Minimally Invasive Autopsy: A New Paradigm for Understanding Global Health? PLoS Med. 13, 8–11 (2016).
 9. Farag, T. H. et al. Precisely tracking childhood death. Am. J. Trop. Med. Hyg. 97, 3–5 (2017).
 10. Morris, J. A., Harrison, L. M. & Partridge, S. M. Practical and theoretical aspects of postmortem bacteriology. Curr. Diagnostic 
Pathol. 13, 65–74 (2007).
 11. Weber, M. et al. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet 371, 1848–1853 
(2008).
 12. Heimesaat, M. M. et al. Comprehensive postmortem analyses of intestinal microbiota changes and bacterial translocation in human 
flora associated mice. PLoS One 7, https://doi.org/10.1371/journal.pone.0040758 (2012).
 13. Morris, J. A. Postmortem bacteriology: a re-evaluation. J. Clin. Pathol. 59, 1–9 (2006).
 14. Mesli, V., Neut, C. & Hedouin, V. Postmortem bacterial translocation in Forensic Microbiology (eds. Carter, D. O., Tomberlin, J. K., 
Benbow, M. E. & Metcalf, J. L.) 192–211 (John Wiley & Sons Ltd, 2017).
 15. Balzan, S. et al. Bacterial translocation: Overview of mechanisms and clinical impact. J. Gastroenterol. Hepatol. 22, 464–471 (2007).
 16. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nat. 2012 486, 222–227 (2012).
 17. Hutchins, G. M., Berman, J. J., Moore, G. W. & Hanzlick, R. Practice guidelines for autopsy pathology: autopsy reporting. Autopsy 
Committee of the College of American Pathologists. Arch. Pathol. Lab. Med. 123, 1085–92 (1999).
 18. Bove, K. E. Practice guidelines for autopsy pathology: the perinatal and pediatric autopsy. Autopsy Committee of the College of 
American Pathologists. Arch. Pathol. Lab. Med. 121, 368–76 (1997).
 19. Martínez, M. J. et al. Infectious cause of death determination using minimally invasive autopsies in developing countries. Diagn. 
Microbiol. Infect. Dis. 84, 80–86 (2016).
 20. World Health Organization (WHO). ICD-10Volume 2 Instruction Manual. (2016). Available at: http://apps.who.int/classifications/
icd10/browse/Content/statichtml/ICD10Volume2_en_2016.pdf?ua=1. (Accessed: 20th December 2017).
 21. Vuong, Q. H. Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses. Econometrica 57, 307 (1989).
 22. Vanbelle, S. & Albert, A. A bootstrap method for comparing correlated kappa coefficients. J. Stat. Comput. Simul. 78, 1009–1015 
(2008).
 23. StataCorp. Stata Statistical Software: Release 14. College Station, Texas. USA. https://www.stata.com/products/ (2015).
 24. Tsokos, M. & Püschel, K. Postmortem bacteriology in forensic pathology: Diagnostic value and interpretation. Leg. Med. 3, 15–22 
(2001).
 25. Caplan, M. J. & Koontz, F. P. in Cumitech 35, Postmortem Microbiology. (ed. McCurdy, B. W.) 1–37 (ASM Press, 2001).
 26. Plantefève, G. & Bleichner, G. Translocation bactérienne: mythe ou réalité? Réanimation. 10, 550–561 (2001).
 27. Lobmaier, I. V. K., Vege, Å., Gaustad, P. & Rognum, T. O. Bacteriological investigation-significance of time lapse after death. Eur. J. 
Clin. Microbiol. Infect. Dis. 28, 1191–1198 (2009).
 28. Laffineur, G. et al. Bacterial translocation in Crohn disease. Gastroentérologie Clin. Biol. 16, 777–81 (1992).
 29. Palmiere, C., Egger, C., Prod’Hom, G. & Greub, G. Bacterial Translocation and Sample Contamination in Postmortem 
Microbiological Analyses. J. Forensic Sci. 61, 367–374 (2016).
 30. Cocariu, E. A. et al. Correlations Between the Autolytic Changes and Postmortem Interval in Refrigerated Cadavers. Rom. J. Intern. 
Med. 54, 105–112 (2016).
 31. George, J., Van Wettere, A. J., Michaels, B. B., Crain, D. & Lewbart, G. A. Histopathologic evaluation of postmortem autolytic 
changes in bluegill (Lepomis macrohirus) and crappie (Pomoxis anularis) at varied time intervals and storage temperatures. PeerJ 4, 
e1943 (2016).
 32. Burcham, Z. M. et al. Fluorescently labeled bacteria provide insight on post-mortem microbial transmigration. Forensic Sci. Int. 264, 
63–69 (2016).
Acknowledgements
We would like to thank the families of the deceased patients included in this study. The authors are grateful to 
all the members of the Department of Pathology of Maputo Central Hospital, whose support made this study 
possible, and to the staff of the Centro de Investigação em Saúde de Manhiça (CISM) for their logistic support. We 
specifically thank Mr. Bento Nhancale for his invaluable support to the study. We also thank the European Society 
for Clinical Microbiology and Infectious Diseases Study Group for Forensic and Postmortem Microbiology 
(ESGFOR) for valuable training and advice. The CaDMIA research project (Validation of the minimally invasive 
www.nature.com/scientificreports/
1 0SCIEntIFIC REPORtS |         (2018) 8:16112  | DOI:10.1038/s41598-018-34436-1
autopsy tool for cause of death investigation in developing countries) was funded by the Bill & Melinda Gates 
Foundation (Global Health grant numbers OPP1067522; QB) (http://www.gatesfoundation.org/) and by the 
Spanish Instituto de Salud Carlos III (FIS, PI12/00757; CM) (https://portalfis.isciii.es). Data analysis has been 
supported by the CaDMIA plus research project, funded by the Bill & Melinda Gates Foundation (Global health 
grant numbers OPP1128001; JO) (http://www.gatesfoundation.org) and the Spanish Instituto de Salud Carlos III 
(Acciones CIBER; CM) (http://www.ciberisciii.es/). ISGlobal is a member of the CERCA Programme, Generalitat 
de Catalunya (http://cerca.cat/en/suma/). CISM is supported by the Government of Mozambique and the Spanish 
Agency for International Development (AECID). No funding bodies had any role in study design, data collection 
and analysis, decision to publish, or preparation of the manuscript.
Author Contributions
J.C.H., L.Q., P.C., Q.B., C.M., M.J.M. and J.O. wrote the main manuscript text. C.C., F.F., D.J., L.L., R.B., T.N., 
P.S.R., S.B., C.S., V.C., S.M., Z.J., F.M., M.R.I., C.L., A.G., A.C., I.M., M.M. and K.M. provided the data from 
Mozambique. J.C.H., L.Q., P.C., M.N., I.C., N.R., L.M., N.C., A.S., C.M.A., Q.B., C.M., M.J.M. and J.O. provided 
the data from Spain. L.Q. prepared Figs 1–3. C.C., A.S., I.M., K.M., E.M., P.A., J.V., Q.B., C.M., M.J.M. and J.O. 
supervised research activity. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-34436-1.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
